Mediators of Inflammation
Volume 2020 (2020), Article ID 7859157, 1 page
https://doi.org/10.1155/2020/7859157

Retraction

Retracted: The Anti-Inflammatory Effects of Shinbaro3 Is Mediated by Downregulation of the TLR4 Signalling Pathway in LPS-Stimulated RAW 264.7 Macrophages

Mediators of Inflammation

Received 14 August 2020; Accepted 14 August 2020; Published 29 September 2020

Copyright © 2020 Mediators of Inflammation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

At the request of the authors, the article titled “The Anti-Inflammatory Effects of Shinbaro3 Is Mediated by Downregulation of the TLR4 Signalling Pathway in LPS-Stimulated RAW 264.7 Macrophages” [1] has been retracted. The authors said that while they were conducting further studies on the inflammatory effects of Shinbaro3, they were not able to confirm the results in this article and the Western blots data shown in Figures 3b, 4a, 4b, 6b need further verification and validation; the original uncropped and unadjusted Western blots are unavailable. The conclusions may lack reliability due to inconsistencies in the results and therefore they are repeating the experiments.

References

H.-J. Chung, W. Koh, W. K. Kim et al., “The Anti-Inflammatory Effects of Shinbaro3 Is Mediated by Downregulation of the TLR4 Signalling Pathway in LPS-Stimulated RAW 264.7 Macrophages,” Mediators of Inflammation, vol. 2018, Article ID 4514329, 14 pages, 2018.